title: Lactobacillus priming of the respiratory tract: Heterologous immunity and protection against lethal pneumovirus infection.
abstract: We showed previously that wild-type mice primed via intranasal inoculation with live or heat-inactivated Lactobacillus species were fully (100%) protected against the lethal sequelae of infection with the virulent pathogen, pneumonia virus of mice (PVM), a response that is associated with diminished expression of proinflammatory cytokines and diminished virus recovery. We show here that 40% of the mice primed with live Lactobacillus survived when PVM challenge was delayed for 5months. This robust and sustained resistance to PVM infection resulting from prior interaction with an otherwise unrelated microbe is a profound example of heterologous immunity. We undertook the present study in order to understand the nature and unique features of this response. We found that intranasal inoculation with L. reuteri elicited rapid, transient neutrophil recruitment in association with proinflammatory mediators (CXCL1, CCL3, CCL2, CXCL10, TNF-alpha and IL-17A) but not Th1 cytokines. IFNγ does not contribute to survival promoted by Lactobacillus-priming. Live L. reuteri detected in lung tissue underwent rapid clearance, and was undetectable at 24h after inoculation. In contrast, L. reuteri peptidoglycan (PGN) and L. reuteri genomic DNA (gDNA) were detected at 24 and 48h after inoculation, respectively. In contrast to live bacteria, intranasal inoculation with isolated L. reuteri gDNA elicited no neutrophil recruitment, had minimal impact on virus recovery and virus-associated production of CCL3, and provided no protection against the negative sequelae of virus infection. Isolated PGN elicited neutrophil recruitment and proinflammatory cytokines but did not promote sustained survival in response to subsequent PVM infection. Overall, further evaluation of the responses leading to Lactobacillus-mediated heterologous immunity may provide insight into novel antiviral preventive modalities.
authors.affiliation: Inflammation Immunobiology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: Katia E
authors.initials: KE
authors.lastname: Garcia-Crespo
authors.forename: Calvin C
authors.initials: CC
authors.lastname: Chan
authors.forename: Stanislaw J
authors.initials: SJ
authors.lastname: Gabryszewski
authors.forename: Caroline M
authors.initials: CM
authors.lastname: Percopo
authors.forename: Peter
authors.initials: P
authors.lastname: Rigaux
authors.forename: Kimberly D
authors.initials: KD
authors.lastname: Dyer
authors.forename: Joseph B
authors.initials: JB
authors.lastname: Domachowske
authors.forename: Helene F
authors.initials: HF
authors.lastname: Rosenberg
mesh_terms: D000818:Animals; D016207:Cytokines / Q000276:immunology; D005260:Female; D006801:Humans; D007109:Immunity; D007778:Lactobacillus / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D029122:Murine pneumonia virus / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D009504:Neutrophils / Q000276:immunology; D018186:Pneumovirus Infections / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control* / Q000821:virology; D012136:Respiratory Syncytial Viruses / Q000276:immunology / Q000502:physiology; D012137:Respiratory System / Q000276:immunology / Q000382:microbiology* / Q000821:virology
chemical_list: D016207:Cytokines